[MNPR] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -12.46%
YoY- -32.79%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -1,715 -2,200 -2,763 -2,080 -1,446 -906 -821 13.05%
Tax -1,789 128,087 -1 -2,092 -1,464 -932 -840 13.41%
NP -1,715 -2,200 -2,762 -2,080 -1,446 -906 -821 13.05%
Tax Rate - - - - - - - -
Total Cost 1,715 2,200 2,762 2,080 1,446 906 821 13.05%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.49 -0.16 -0.22 -0.17 -0.14 -0.09 -0.07 38.26%
EPS Diluted -0.49 -0.16 -0.22 -0.17 -0.14 -0.09 -0.07 38.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.